SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Novartis
Novartis
Page 2 of 4
Leadership
Novartis CEO: It’s Time to “Pivot Towards Transformational Innovation”
By
Susie Gharib
March 20, 2019
Net Drug Prices Are Falling, Even as List Prices Increase
By
Renae Reints
January 30, 2019
Canadian Pot Firm Tilray Goes Global With Novartis Marijuana Deal
By
Bloomberg
December 18, 2018
Health
Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO
By
Sy Mukherjee
October 11, 2018
Health
Drug Giant Novartis Is Temporarily Backing Off Price Increases Following Trump Pressure
By
Sy Mukherjee
July 19, 2018
Health
Novartis Is Spinning Off Its Alcon Eye Care Business and Launching a $5 Billion Share Buyback
By
Sy Mukherjee
June 29, 2018
Health
The FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
By
David Meyer
May 18, 2018
Health
The FDA Is Naming and Shaming Companies Accused of Blocking Cheap Generic Drugs
By
Sy Mukherjee
May 17, 2018
Leadership
Top Novartis Lawyer Exits Over the $1.2 Million It Paid to Trump Lawyer Michael Cohen
By
David Meyer
May 16, 2018
Health
That $1.2 Million Payment to Trump’s Lawyer Wasn’t Even a Drop in the Bucket for Novartis
By
Sy Mukherjee
May 10, 2018
Health
Novartis Put Money In Michael Cohen’s Cookie Jar. Did It Get Any Cookies In Return?
By
Clifton Leaf
May 9, 2018
Health
Why Analysts Are Calling Celgene’s $9 Billion Juno Acquisition a ‘Smart’ Biotech Deal
By
Sy Mukherjee
January 22, 2018
Health
The First FDA-Approved Gene Therapy Can Cure a Type of Blindness—But May Cost $1 Million
By
Sy Mukherjee
December 19, 2017
Health
Gene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?
By
Sy Mukherjee
November 16, 2017
Health
We’ve Had Terrible Luck Trying to Cure Alzheimer’s. But What If We Could Prevent It?
By
Sy Mukherjee
November 2, 2017
Most Popular
North America
'The frustration is overwhelming': Soybean farmers feel betrayed as Argentina blows a hole in rural America’s $47...
By
Sasha Rogelberg
Success
Gen Z is reviving this boring job that millennials and boomers abandoned—and it's helping them land six-figure careers...
By
Preston Fore
Investing
Trump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for US consumers,’...
By
Jim Edwards